Translational Development Acquisition Corp. (TDAC) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−159.6x

Market Cap

$209.40M

MomentumView details →

1D Return

−0.05%

YTD Return

+3.43%

RSI (14)

60.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−159.6x

Market Cap

$209.40M

RSI (14)

60.2

MomentumView details →

1D Return

−0.05%

YTD Return

+3.43%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

3.70%

ROA (TTM)

3.52%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

−39.74%

FCF YoY

—

Revenue CAGR 3Y

−100.00%

EPS CAGR 3Y

+2383.95%

EBITDA YoY

−72.34%

EarningsView details →

EPS (Actual)

$0.04

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

0.06x

Quick Ratio

0.06x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

5.54M

Op. CF (TTM)

−849378.00

Latest newsMore news →

ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.39d ago

Translational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.61d ago

Similar companies

Space Asset Acquisition Corp. UnitsSAAQU Abony Acquisition Corp. I UnitsAACOU Harvard Ave Acquisition Corporation Class A Ordinary ShareHAVA Vendome Acquisition Corporation I UnitVNMEU EGH Acquisition Corp. Class A Ordinary SharesEGHA Iron Dome Acquisition I Corp.IDAC Find similar companies →

Latest newsMore news →

ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.39d ago Translational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.61d ago